REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY: Real-World Assessment of Myeloma Patients As Candidates for CAR-T Therapy. Mediterr J Hematol Infect Dis 2020, 13 (1), e2021012. https://doi.org/10.4084/mjhid.2021.012.